Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference

Core Insights - Insmed Incorporated is set to present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026, at 3:00 p.m. PT / 6:00 p.m. ET [1] - The presentation will be available via a live webcast on the company's investor relations website, with an archive accessible for 30 days post-event [2] Company Overview - Insmed is a global biopharmaceutical company focused on delivering first- and best-in-class therapies for patients with serious diseases [3] - The company has a diverse portfolio that includes approved and mid- to late-stage investigational medicines, particularly in pulmonary and inflammatory conditions, with two approved therapies for chronic lung diseases [3] - Insmed's early-stage programs utilize various advanced technologies, including gene therapy, AI-driven protein engineering, and synthetic rescue [3] - Headquartered in Bridgewater, New Jersey, Insmed operates research locations across the U.S., Europe, and Japan, and has been recognized as a top employer in the biopharmaceutical industry [4]